Vector BioPharma

Virus-like particles
#Biopharmaceuticals #Cell and gene therapy #Collaboration #Gene delivery #Gene therapy #Partnership #Vector BioPharma

Vector and iBET collaborate to accelerate gene delivery platform

Vector BioPharma and the Instituto de Biologia Experimental e Tecnológica (iBET) have agreed a multi-phase collaboration to advance the technical development of Vector’s gene delivery platform.  Vector BioPharma’s gene delivery platform combines high-capacity virus-like particles with exogenous, high-avidity adapter proteins.  Lorenz Mayr, CEO at Vector BioPharma, said: “Collaboration with industry-leading… Read More

#Business & Investment #News